Pennsylvania | 000-00121 | 23-1498399 | ||||||||||||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common Stock, Without Par Value | KLIC | The Nasdaq Global Market |
Item 9.01 |
Financial Statements and Exhibits. |
|||||||
(d) | Exhibits. | |||||||
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Inline XBRL for the cover page of this Current Report on Form 8‑K. | |||||||
KULICKE AND SOFFA INDUSTRIES, INC. | |||||||||||
Date: August 3, 2022 | By: | /s/ LESTER WONG | |||||||||
Name: | Lester Wong | ||||||||||
Title: | Executive Vice President and Chief Financial Officer | ||||||||||
![]() |
Kulicke & Soffa Pte. Ltd.
23A Serangoon North Ave 5
Singapore 554369
+65 6880-9600 main
Co. Regn. No. 199902120H
|
||||
Kulicke and Soffa Industries, Inc.
1005 Virginia Drive
Fort Washington, PA 19034 USA
+1-215-784-6000 main
www.kns.com
|
Quarterly Results - U.S. GAAP | |||||||||||
Fiscal Q3 2022 |
Change vs. Fiscal Q3 2021 |
Change vs. Fiscal Q2 2022 |
|||||||||
Net Revenue | $372.1 million | down 12.3% | down 3.2% | ||||||||
Gross Profit | $190.7 million | down 2.6% | down 5.5% | ||||||||
Gross Margin | 51.2% | up 510 bps | down 130 bps | ||||||||
Income from Operations | $122.1 million | up 1.3% | down 5.6% | ||||||||
Operating Margin | 32.8% | up 440 bps | down 90 bps | ||||||||
Net Income | $119.0 million | up 4.6% | up 2.6% | ||||||||
Net Margin | 32.0% | up 520 bps | up 180 bps | ||||||||
EPS – Diluted | $1.99 | up 11.2% | up 7% |
Quarterly Results - Non-GAAP | |||||||||||
Fiscal Q3 2022 |
Change vs. Fiscal Q3 2021 |
Change vs. Fiscal Q2 2022 |
|||||||||
Income from Operations | $129.0 million | up 2.5% | down 4.6% | ||||||||
Operating Margin | 34.7% | up 500 bps | down 50 bps | ||||||||
Net Income | $125.1 million | up 5.3% | up 3% | ||||||||
Net Margin | 33.6% | up 560 bps | up 200 bps | ||||||||
EPS – Diluted | $2.09 | up 11.8% | up 7.2% |
Kulicke & Soffa Industries, Inc. | |||||
Joseph Elgindy | |||||
Investor Relations | |||||
P: +1-215-784-7518 | |||||
F: +1-215-784-6180 | |||||
Three months ended | Nine months ended | ||||||||||||||||||||||
July 2, 2022 | July 3, 2021 | July 2, 2022 | July 3, 2021 | ||||||||||||||||||||
Net revenue | $ | 372,137 | $ | 424,318 | $ | 1,217,307 | $ | 1,032,338 | |||||||||||||||
Cost of sales | 181,452 | 228,623 | 601,674 | 566,667 | |||||||||||||||||||
Gross profit | 190,685 | 195,695 | 615,633 | 465,671 | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Selling, general and administrative | 33,453 | 37,763 | 104,940 | 99,038 | |||||||||||||||||||
Research and development | 34,046 | 36,137 | 104,496 | 102,549 | |||||||||||||||||||
Amortization of intangible assets | 1,109 | 1,340 | 3,543 | 4,652 | |||||||||||||||||||
Acquisition-related costs | — | — | — | 1,730 | |||||||||||||||||||
Restructuring | — | — | 126 | 91 | |||||||||||||||||||
Total operating expenses | 68,608 | 75,240 | 213,105 | 208,060 | |||||||||||||||||||
Income from operations | 122,077 | 120,455 | 402,528 | 257,611 | |||||||||||||||||||
Other income (expense): | |||||||||||||||||||||||
Interest income | 2,158 | 564 | 3,099 | 1,801 | |||||||||||||||||||
Interest expense | (36) | (41) | (173) | (146) | |||||||||||||||||||
Income before income taxes | 124,199 | 120,978 | 405,454 | 259,266 | |||||||||||||||||||
Income tax expense | 5,165 | 7,212 | 36,813 | 25,722 | |||||||||||||||||||
Share of results of equity-method investee, net of tax | — | — | — | 94 | |||||||||||||||||||
Net income | $ | 119,034 | $ | 113,766 | $ | 368,641 | $ | 233,450 | |||||||||||||||
Net income per share: | |||||||||||||||||||||||
Basic | $ | 2.02 | $ | 1.83 | $ | 6.05 | $ | 3.76 | |||||||||||||||
Diluted | $ | 1.99 | $ | 1.79 | $ | 5.95 | $ | 3.68 | |||||||||||||||
Cash dividends declared per share | $ | 0.17 | $ | 0.14 | $ | 0.51 | $ | 0.42 | |||||||||||||||
Weighted average shares outstanding: | |||||||||||||||||||||||
Basic | 58,985 | 62,023 | 60,951 | 62,023 | |||||||||||||||||||
Diluted | 59,955 | 63,485 | 61,940 | 63,364 |
Three months ended | Nine months ended | ||||||||||||||||||||||
Supplemental financial data: | July 2, 2022 | July 3, 2021 | July 2, 2022 | July 3, 2021 | |||||||||||||||||||
Depreciation and amortization | $ | 5,210 | $ | 4,805 | $ | 15,773 | $ | 14,552 | |||||||||||||||
Capital expenditures | 4,953 | 7,956 | 11,213 | 16,763 | |||||||||||||||||||
Equity-based compensation expense: | |||||||||||||||||||||||
Cost of sales | 193 | 211 | 727 | 626 | |||||||||||||||||||
Selling, general and administrative | 3,233 | 3,008 | 10,485 | 8,111 | |||||||||||||||||||
Research and development | 1,039 | 921 | 3,261 | 2,767 | |||||||||||||||||||
Total equity-based compensation expense | $ | 4,465 | $ | 4,140 | $ | 14,473 | $ | 11,504 |
As of | |||||||||||
July 2, 2022 | July 3, 2021 | ||||||||||
Number of employees | 3,405 | 3,583 |
As of | |||||||||||
July 2, 2022 | October 2, 2021 | ||||||||||
ASSETS | |||||||||||
CURRENT ASSETS | |||||||||||
Cash and cash equivalents | $ | 445,781 | $ | 362,788 | |||||||
Short-term investments | 300,000 | 377,000 | |||||||||
Accounts and other receivable, net of allowance for doubtful accounts of $0 and $687, respectively | 350,045 | 421,193 | |||||||||
Inventories, net | 215,281 | 167,323 | |||||||||
Prepaid expenses and other current assets | 75,011 | 23,586 | |||||||||
TOTAL CURRENT ASSETS | 1,386,118 | 1,351,890 | |||||||||
Property, plant and equipment, net | 66,510 | 67,982 | |||||||||
Operating right-of-use assets | 41,160 | 41,592 | |||||||||
Goodwill | 69,787 | 72,949 | |||||||||
Intangible assets, net | 35,291 | 42,752 | |||||||||
Deferred tax assets | 21,103 | 15,715 | |||||||||
Equity investments | 5,397 | 6,388 | |||||||||
Other assets | 2,911 | 2,363 | |||||||||
TOTAL ASSETS | $ | 1,628,277 | $ | 1,601,631 | |||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||
CURRENT LIABILITIES | |||||||||||
Accounts payable | 98,572 | 154,636 | |||||||||
Operating lease liabilities | 5,973 | 4,903 | |||||||||
Accrued expenses and other current liabilities | 138,434 | 161,570 | |||||||||
Income taxes payable | 31,060 | 30,766 | |||||||||
TOTAL CURRENT LIABILITIES | 274,039 | 351,875 | |||||||||
Deferred income taxes | 34,541 | 32,828 | |||||||||
Income taxes payable | 62,468 | 69,422 | |||||||||
Operating lease liabilities | 35,836 | 38,084 | |||||||||
Other liabilities | 14,660 | 14,185 | |||||||||
TOTAL LIABILITIES | 421,544 | 506,394 | |||||||||
SHAREHOLDERS' EQUITY | |||||||||||
Common stock, no par value | 557,236 | 550,117 | |||||||||
Treasury stock, at cost | (615,689) | (400,412) | |||||||||
Retained earnings | 1,286,505 | 948,554 | |||||||||
Accumulated other comprehensive loss | (21,319) | (3,022) | |||||||||
TOTAL SHAREHOLDERS' EQUITY | $ | 1,206,733 | $ | 1,095,237 | |||||||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ | 1,628,277 | $ | 1,601,631 |
Three months ended | Nine months ended | ||||||||||||||||||||||
July 2, 2022 | July 3, 2021 | July 2, 2022 | July 3, 2021 | ||||||||||||||||||||
Net cash provided by operating activities | $ | 104,616 | $ | 90,936 | $ | 273,625 | $ | 176,656 | |||||||||||||||
Net cash (used in) / provided by investing activities | (75,119) | 52,222 | 66,342 | 54,221 | |||||||||||||||||||
Net cash used in financing activities | (39,841) | (12,865) | (250,905) | (31,982) | |||||||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | (4,328) | 373 | (6,069) | 977 | |||||||||||||||||||
Changes in cash and cash equivalents | (14,672) | 130,666 | 82,993 | 199,872 | |||||||||||||||||||
Cash and cash equivalents, beginning of period | 460,453 | 257,333 | 362,788 | 188,127 | |||||||||||||||||||
Cash and cash equivalents, end of period | $ | 445,781 | $ | 387,999 | $ | 445,781 | $ | 387,999 | |||||||||||||||
Short-term investments | 300,000 | 247,000 | 300,000 | 247,000 | |||||||||||||||||||
Total cash, cash equivalents and short-term investments | $ | 745,781 | $ | 634,999 | $ | 745,781 | $ | 634,999 | |||||||||||||||
Three months ended | ||||||||||||||||||||
July 2, 2022 | July 3, 2021 | April 2, 2022 | ||||||||||||||||||
Net revenue | $ | 372,137 | $ | 424,318 | $ | 384,282 | ||||||||||||||
U.S. GAAP income from operations | 122,077 | 120,455 | 129,341 | |||||||||||||||||
U.S. GAAP operating margin | 32.8 | % | 28.4 | % | 33.7 | % | ||||||||||||||
Pre-tax non-GAAP items: | ||||||||||||||||||||
Amortization related to intangible assets acquired through business combination- selling, general and administrative | 1,109 | 1,340 | 1,151 | |||||||||||||||||
Equity-based compensation | 4,465 | 4,140 | 4,696 | |||||||||||||||||
Impairment charges | 1,346 | — | — | |||||||||||||||||
Non-GAAP income from operations | $ | 128,997 | $ | 125,935 | $ | 135,188 | ||||||||||||||
Non-GAAP operating margin | 34.7 | % | 29.7 | % | 35.2 | % | ||||||||||||||
Three months ended | ||||||||||||||||||||
July 2, 2022 | July 3, 2021 | April 2, 2022 | ||||||||||||||||||
Net revenue | $ | 372,137 | $ | 424,318 | $ | 384,282 | ||||||||||||||
U.S. GAAP net income | 119,034 | 113,766 | 116,001 | |||||||||||||||||
U.S. GAAP net margin | 32.0 | % | 26.8 | % | 30.2 | % | ||||||||||||||
Non-GAAP adjustments: | ||||||||||||||||||||
Amortization related to intangible assets acquired through business combination- selling, general and administrative | 1,109 | 1,340 | 1,151 | |||||||||||||||||
Equity-based compensation | 4,465 | 4,140 | 4,696 | |||||||||||||||||
Impairment charges | 1,346 | — | — | |||||||||||||||||
Net income tax (benefit)/expense on non-GAAP items | (865) | (460) | (385) | |||||||||||||||||
Total non-GAAP adjustments | $ | 6,055 | $ | 5,020 | $ | 5,462 | ||||||||||||||
Non-GAAP net income | $ | 125,089 | $ | 118,786 | $ | 121,463 | ||||||||||||||
Non-GAAP net margin | 33.6 | % | 28.0 | % | 31.6 | % | ||||||||||||||
U.S. GAAP net income per share: | ||||||||||||||||||||
Basic | 2.02 | 1.83 | 1.89 | |||||||||||||||||
Diluted(a) |
1.99 | 1.79 | 1.86 | |||||||||||||||||
Non-GAAP adjustments per share:(b) |
||||||||||||||||||||
Basic | 0.10 | 0.08 | 0.09 | |||||||||||||||||
Diluted | 0.10 | 0.08 | 0.09 | |||||||||||||||||
Non-GAAP net income per share: | ||||||||||||||||||||
Basic | $ | 2.12 | $ | 1.91 | $ | 1.98 | ||||||||||||||
Diluted(c) |
$ | 2.09 | $ | 1.87 | $ | 1.95 | ||||||||||||||
Weighted average shares outstanding: | ||||||||||||||||||||
Basic | 58,985 | 62,023 | 61,482 | |||||||||||||||||
Diluted | 59,955 | 63,485 | 62,435 | |||||||||||||||||